Plain-English translation of NCT07480356 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing a new medication called to see if it can effectively treat high-grade early-stage bladder cancer (cancer that has not spread into the muscle layer of the bladder). Researchers will compare this medication to standard chemotherapy treatments to find out whether it works better, is safer, or causes fewer side effects. The trial will enroll about 284 adults with this type of bladder cancer.
Many people with high-grade early-stage bladder cancer are treated with a medicine called BCG, but not everyone responds well to it or can tolerate it. This trial is testing whether this medication could offer a new or better treatment option for patients who haven't tried BCG yet or who need an alternative approach.
You likely qualify if…
You likely don't qualify if…
If you are enrolled, you will be randomly assigned to receive either or a standard chemotherapy treatment that your doctor chooses. The medication is delivered directly into your bladder through a catheter (a thin tube). You will visit the study clinic for treatments and follow-up appointments to have your cancer monitored and to report any side effects you experience. The study team will track how well the treatment works and monitor your safety throughout the trial.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
United States